B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Gsk 1070916

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Gsk 1070916, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

osi
19 shared targets
cabozantinib
14 shared targets
cyc
26 shared targets
lenvatinib
13 shared targets
mk
12 shared targets
cediranib
20 shared targets
danusertib
19 shared targets
pazopanib
23 shared targets
raf
16 shared targets
k
20 shared targets
Loading evidence profile...

This evidence profile for Gsk 1070916 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.